Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Gastrinoma × epothilone B × NET × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Vipoma 1 Neuroendocrine Tumors 1 Neoplasms 1 Neoplasm Metastasis 1 Gastrinoma 1 Carcinoma 1 Carcinoid Tumor 1

Interventions

motesanib diphosphate 1 epothilone B 1 batifiban 1 Temozolomide 1 Oxaliplatin 1 Octreotide 1 Leucovorin 1 Fluorouracil 1 Capecitabine 1 Bevacizumab 1 177Lu-octreotide, DOTA(0)-Tyr(3)- 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00050349 2017-03-01

EPO906 in Carcinoid and Other Neuroendocrine Tumors

Novartis

Phase 2 Completed

Carcinoid Tumor, Carcinoma, Vipoma, Neoplasm Metastasis, Neoplasms, Gastrinoma, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡